These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 9738856
1. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. Goldstein BP, Wei J, Greenberg K, Novick R. J Antimicrob Chemother; 1998 Aug; 42(2):277-8. PubMed ID: 9738856 [No Abstract] [Full Text] [Related]
2. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J, Yoshida O, Hayashi S, Arimoto H. Chem Commun (Camb); 2007 Jan 21; (3):251-3. PubMed ID: 17299629 [Abstract] [Full Text] [Related]
3. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae. Knudsen JD. Dan Med Bull; 2000 Nov 21; 47(5):313-27. PubMed ID: 11155659 [Abstract] [Full Text] [Related]
4. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Viladrich PF, Gudiol F. J Antimicrob Chemother; 2006 May 21; 57(5):931-6. PubMed ID: 16507562 [Abstract] [Full Text] [Related]
5. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy. Torres-Tortosa M, Caballero-Granado J, Canueto J, Moreno-Maqueda I. Clin Infect Dis; 2004 Mar 01; 38(5):763-4; author reply 765-6. PubMed ID: 14986265 [No Abstract] [Full Text] [Related]
6. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002). Jones RN, Sader HS, Fritsche TR. Diagn Microbiol Infect Dis; 2004 Jun 01; 49(2):147-9. PubMed ID: 15183865 [Abstract] [Full Text] [Related]
7. Rabbit Streptococcus pneumoniae keratitis model and topical therapy. Guzek JP, Cline DJ, Row PK, Wessels IF, Beeve S, Ispirescu S, Aprecio RM, Kettering JD, Gano DL, Nelson GM. Invest Ophthalmol Vis Sci; 1998 Oct 01; 39(11):2012-7. PubMed ID: 9761279 [Abstract] [Full Text] [Related]
8. Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation. Sader H, Del'Alamo L. Braz J Infect Dis; 2000 Oct 01; 4(5):268-70. PubMed ID: 11063559 [No Abstract] [Full Text] [Related]
9. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Novak R, Henriques B, Charpentier E, Normark S, Tuomanen E. Nature; 1999 Jun 10; 399(6736):590-3. PubMed ID: 10376600 [Abstract] [Full Text] [Related]
10. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae]. Soriano F. Med Clin (Barc); 1999 Jun 26; 113(3):103-8. PubMed ID: 10464745 [No Abstract] [Full Text] [Related]
12. In-vitro activity of nisin against clinical isolates of Clostridium difficile. Bartoloni A, Mantella A, Goldstein BP, Dei R, Benedetti M, Sbaragli S, Paradisi F. J Chemother; 2004 Apr 10; 16(2):119-21. PubMed ID: 15216943 [Abstract] [Full Text] [Related]
13. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor. Gross M, Clements J, Beckett RP, Thomas W, Taylor S, Lofland D, Ramanathan-Girish S, Garcia M, Difuntorum S, Hoch U, Chen H, Johnson KW. J Antimicrob Chemother; 2004 Mar 10; 53(3):487-93. PubMed ID: 14963065 [Abstract] [Full Text] [Related]
14. Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae. Tarragó D, Lara N, Fenoll A, Casal J, Giménez MJ, Aguilar L, Sevillano D. Antimicrob Agents Chemother; 2005 Jul 10; 49(7):3095-6. PubMed ID: 15980409 [No Abstract] [Full Text] [Related]
15. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. Siegel M, Timpone J. Clin Infect Dis; 2001 Mar 15; 32(6):972-4. PubMed ID: 11247720 [Abstract] [Full Text] [Related]